Palivizumab Medication Information

Discover comprehensive details about Palivizumab, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.

Additionally, explore the Palivizumab brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.

Generic Name : Palivizumab

Pronunciation : pal-i-VIZ-u-mab

ICD Code : Y43.4 Therapeutic Classification : Monoclonal antibodies

Brand Names or Trade Names of Palivizumab

International :

Synagis

Why is Palivizumab Prescribed? (Indications)

This medication is a monoclonal antibody, prescribed for respiratory syncytial virus (RSV) disease in pediatric patients.

When should Palivizumab not be taken? (Contraindications)

Hypersensitivity.

What is the dosage of Palivizumab?

Adult- IM- The recommended dose is 15 mg/kg of body weight.

How should Palivizumab be taken?

It comes as a solution for injection to be administered by a healthcare provider into a large muscle.

What are the warnings and precautions for Palivizumab?

• Caution should be exercised in patients with history of bleeding disorder or low platelet count, heart surgery, who are taking anticoagulants, any allergy, during pregnancy and breastfeeding.